Analyzing...
| # | Symbol | Name | MCap | ROE | ROCE | Growth 3yr | D/E | Margin |
|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | Sun Pharmaceutical Industries Ltd | ₹4.41 Lakh Cr | 13.7% | 17.9% | 10.7% | 0.05x | 19.0% |
| 2 | DIVISLAB | Divi's Laboratories Ltd | ₹1.76 Lakh Cr | 15.3% | 19.0% | 10.9% | 0.00x | 23.2% |
| 3 | TORNTPHARM | Torrent Pharmaceuticals Ltd | ₹1.52 Lakh Cr | 25.8% | 9.1% | 12.8% | 1.76x | 15.6% |
| 4 | CIPLA | Cipla Ltd | ₹1.15 Lakh Cr | 11.3% | 14.9% | 7.7% | 0.01x | 13.4% |
| 5 | DRREDDY | Dr Reddy's Laboratories Ltd | ₹1.09 Lakh Cr | 11.1% | 13.9% | 10.9% | 0.17x | 12.0% |
| 6 | LUPIN | Lupin Ltd | ₹1.03 Lakh Cr | 23.8% | 28.4% | 19.3% | 0.26x | 18.8% |
| 7 | ZYDUSLIFE | Zydus Lifesciences Ltd | ₹1.02 Lakh Cr | 18.6% | 19.2% | 16.7% | 0.43x | 18.2% |
| 8 | MANKIND | Mankind Pharma Ltd | ₹1.02 Lakh Cr | 11.7% | 13.7% | 18.1% | 0.39x | 13.1% |
| 9 | AUROPHARMA | Aurobindo Pharma Ltd | ₹89,995 Cr | 9.3% | 13.6% | 10.7% | 0.20x | 10.3% |
| 10 | LAURUSLABS | Laurus Labs Ltd | ₹72,611 Cr | 16.8% | 19.7% | 4.3% | 0.45x | 12.9% |
| 11 | BIOCON | Biocon Ltd | ₹69,675 Cr | 1.1% | 2.9% | 14.3% | 0.44x | 2.2% |
| 12 | ALKEM | Alkem Laboratories Ltd | ₹63,190 Cr | 16.7% | 18.8% | 9.0% | 0.12x | 15.0% |
| 13 | GLENMARK | Glenmark Pharmaceuticals Ltd | ₹60,645 Cr | - | 16.2% | 9.4% | 0.00x | - |
| 14 | ABBOTINDIA | Abbott India Ltd | ₹57,054 Cr | 32.5% | 41.9% | - | 0.00x | 21.5% |
| 15 | ANTHEM | Anthem Biosciences Ltd | ₹43,778 Cr | 21.1% | 28.0% | - | 0.01x | 29.5% |
| 16 | GLAXO | GlaxoSmithKline Pharmaceuticals Ltd | ₹40,452 Cr | 45.7% | 55.4% | 5.8% | 0.00x | 26.1% |
| 17 | JBCHEPHARM | JB Chemicals & Pharmaceuticals Ltd | ₹39,369 Cr | 17.1% | 21.9% | 10.0% | 0.00x | 16.9% |
| 18 | IPCALAB | IPCA Laboratories Ltd | ₹37,929 Cr | 14.1% | 16.4% | 15.5% | 0.09x | 11.6% |
| 19 | AJANTPHARM | Ajanta Pharma Ltd | ₹37,893 Cr | 23.3% | 29.4% | 13.6% | 0.05x | 18.8% |
| 20 | GLAND | Gland Pharma Ltd | ₹36,841 Cr | 9.9% | 13.7% | 20.4% | 0.02x | 15.2% |